200 related articles for article (PubMed ID: 28218035)
1. MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase.
Liu Z; Wang J; Li Y; Fan J; Chen L; Xu R
Tumour Biol; 2017 Feb; 39(2):1010428317691429. PubMed ID: 28218035
[TBL] [Abstract][Full Text] [Related]
2. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells.
de Los Santos-Jiménez J; Campos-Sandoval JA; Márquez-Torres C; Urbano-Polo N; Brøndegaard D; Martín-Rufián M; Lobo C; Peñalver A; Gómez-García MC; Martín-Campos J; Cardona C; Castilla L; da Costa Souza F; Cheng T; Segura JA; Alonso FJ; Curi R; Colquhoun A; DeBerardinis RJ; Márquez J; Matés JM
J Biomed Sci; 2021 Feb; 28(1):14. PubMed ID: 33610185
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism.
Chang X; Zhu W; Zhang H; Lian S
Clin Exp Dermatol; 2017 Aug; 42(6):614-621. PubMed ID: 28597996
[TBL] [Abstract][Full Text] [Related]
4. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
Luan W; Zhou Z; Zhu Y; Xia Y; Wang J; Xu B
Biochem Biophys Res Commun; 2018 Jan; 495(1):46-52. PubMed ID: 29097210
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
Zhang S; Lai N; Liao K; Sun J; Lin Y
Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
[TBL] [Abstract][Full Text] [Related]
6. Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.
Szeliga M; Albrecht J
Neurochem Int; 2015 Sep; 88():6-9. PubMed ID: 25529918
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor GATA3 expression is induced by GLS2 overexpression in a glioblastoma cell line but is GLS2-independent in patient-derived glioblastoma.
Majewska E; Rola R; Barczewska M; Marquez J; Albrecht J; Szeliga M
J Physiol Pharmacol; 2017 Apr; 68(2):209-214. PubMed ID: 28614770
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c exacerbates the ischemia/reperfusion injury of heart through targeting the glutaminase (GLS)-mediated glutamine metabolism.
Liu F; Li Y; Liu G
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3282-3289. PubMed ID: 28770953
[TBL] [Abstract][Full Text] [Related]
10. LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.
Zhou Q; Zhan H; Lin F; Liu Y; Yang K; Gao Q; Ding M; Liu Y; Huang W; Cai Z
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902882
[TBL] [Abstract][Full Text] [Related]
11. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
Gao P; Tchernyshyov I; Chang TC; Lee YS; Kita K; Ochi T; Zeller KI; De Marzo AM; Van Eyk JE; Mendell JT; Dang CV
Nature; 2009 Apr; 458(7239):762-5. PubMed ID: 19219026
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-197 inhibits cell proliferation by targeting GAB2 in glioblastoma.
Tian LQ; Liu EQ; Zhu XD; Wang XG; Li J; Xu GM
Mol Med Rep; 2016 May; 13(5):4279-88. PubMed ID: 27035789
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Chan JA; Krichevsky AM; Kosik KS
Cancer Res; 2005 Jul; 65(14):6029-33. PubMed ID: 16024602
[TBL] [Abstract][Full Text] [Related]
14. Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway.
Restall IJ; Cseh O; Richards LM; Pugh TJ; Luchman HA; Weiss S
Cancer Res; 2020 Dec; 80(24):5478-5490. PubMed ID: 33106333
[TBL] [Abstract][Full Text] [Related]
15. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
[TBL] [Abstract][Full Text] [Related]
16. Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.
Chen L; Cui H
Int J Mol Sci; 2015 Sep; 16(9):22830-55. PubMed ID: 26402672
[TBL] [Abstract][Full Text] [Related]
17. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
Kefas B; Godlewski J; Comeau L; Li Y; Abounader R; Hawkinson M; Lee J; Fine H; Chiocca EA; Lawler S; Purow B
Cancer Res; 2008 May; 68(10):3566-72. PubMed ID: 18483236
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.
Teplyuk NM; Uhlmann EJ; Wong AH; Karmali P; Basu M; Gabriely G; Jain A; Wang Y; Chiocca EA; Stephens R; Marcusson E; Yi M; Krichevsky AM
Oncotarget; 2015 Feb; 6(6):3770-83. PubMed ID: 25738367
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
[TBL] [Abstract][Full Text] [Related]
20. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
